PCOS Has A New Name! PMOS

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts 1 in 8, or more than 170 million women worldwide.

In our Pathways to Care for PCOS-PMOS in Alberta, assessing cardiometabolic risk at diagnosis is key to better care for those with PMOS (see below).

The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), has just been published in The Lancet and is being announced currently at the European Congress of Endocrinology Conference May 2026.

Here are some resources and videos for you to share with your networks – https://bit.ly/3V85nPJ. There are patient and health professionals resources that have been translated in English, Arabic, Persian, Mandarin, German, Spanish, Portuguese, French, German and other languages.

For more information:  https://www.mchri.org.au/guidelines-resources/community/pcos-resources-2/

PMOS Clinical Pathway:  Primary Care Pathway (albertahealthservices.ca)

PMOS Patient Pathway Web Content:  Pathway (alberta.ca)

PMOS Patient Pathway Summary (which is linked to the clinical pathway): Your Journey with PMOS (alberta.ca)

PMOS Patient Pathway (Full): Your Journey with PMOS (alberta.ca)

Here is why PCOS is now PMOS

PCOS, which affects tens of millions of women, is now known as PMOS. Here's why the renaming is important

PMOS Patient Partner Featured at Ceremony for Largest Gift in UofA History for Women’s and Children’s Health

2024-2025 WCHRI Report: Dr. Vine, Researcher creates key resources for PMOS diagnosis and care

Award for 2025 Top Fundraising Team: Run For Women

AE-PCOS (2024) Annual Meeting: Verity PCOS UK Poster Award for Best Patient Engagement for the Pathways to Care and our Heart Health studies

YouTube: What is researcher Dr. Donna Vine doing to change healthcare for women?

YouTube:What is researcher Dr. Donna Vine doing to change healthcare for women? #iwd2024 #inspireinclusion

Surveying the Silence: Alberta Women's Health Foundation Report, February 1, 2023

For the full report from the Alberta Women's Health Foundation, Surveying the Silence, please click the following link: https://www.albertawomenshealthfoundation.org/our-impact/surveying-the-silence

Dr. Donna Vine Awarded "International Women's Day 2023" from the University of Alberta

University of Alberta The Quad, March 7, 2023, "Celebrating International Women's Day 2023  The stories and achievements of eight of the many women at the U of A whose work challenges the status quo."   Donna Vine's research on polycystic ovary syndrome was highlighted in a survey results report that calls for more awareness and clinician and patient education on women's health.

 

PMOS Together in the UofA Folio, September 19, 2022

For the full article click the following link: More awareness, education needed to better treat polycystic ovary syndrome | Folio (ualberta.ca)

PMOS Together on Global News, Health Matters on Monday, May 31, 2021, 6pm

     

Our Mission

PMOS Together's mission  is to improve our understanding of health outcomes and  health care in women with and without  PMOS in Canada. The focus is on  cardiometabolic risk, diabetes and cardiovascular disease and improving health care in those with PMOS.

Our Research

PMOS Together is a research program aimed at understanding the health status and improving the health and health care of women with PMOS. To do this we are trying to understand the health risks and long term health outcomes in women with PMOS. We have found that women with PMOS in Alberta are at 2 and 3 fold higher risk for developing diabetes and cardiovascular disease.  We are establishing methods to detect early disease risk in women with PMOS. We are also undertaking clinical interventions to treat high-risk women with PMOS in the prevention of diabetes and cardiovascular disease.

Our Studies

We have several studies that you can learn more about:

  1. Heart health in women with and without PMOS  (RECRUITING NOW-CLICK HERE)
  2. Understanding health care and nutrition services in women with PMOS  
  3. Health outcomes in women with and without PMOS  
  4. Fish oil-metformin improves blood lipids in high-risk women with PMOS  
  5. Eating habits and disordered eating patterns in those with and without PMOS
  6. Tracking early cardiovascular disease progression in young women with and without PMOS
  7. PMOS-Fish oil Metformin (PMOS-FM) therapy to reduce blood lipids and early cardiovascular disease progression in high-risk women with PMOS  (RECRUITING NOW-CLICK HERE)
  8. Establishing a Primary Pathway to Care to Improve Health Outcomes in High-Risk Women with Obesity and PMOS

Current Studies: Recruiting Now!

 

 

YouTube-Women's Health in Focus: PCOS in Primary Care

 

Pink Flow’d Podcast: Dr. Vine Interviewed by Mina, McGill Medical Student

 

Eating Disorders in PCOS: a podcast

 

Podcast on PCOS and PCOS Together Research:

 

Find out about PCOS Together news, events and research studies...sign up for our email out!

Social Media

 

@PCOS Together